PUBLISHER: TechNavio | PRODUCT CODE: 1916086
PUBLISHER: TechNavio | PRODUCT CODE: 1916086
Global Whole Exome Sequencing Market 2025-2029
The global whole exome sequencing market is forecasted to grow by USD 3742.8 mn during 2024-2029, accelerating at a CAGR of 21.1% during the forecast period. The report on the global whole exome sequencing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements and precipitous decline in sequencing costs, expanding clinical utility and integration into standard diagnostic workflows, proliferation of large scale government and private precision medicine initiatives.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 20.6% |
| CAGR | 21.1% |
| Incremental Value | $3742.8 mn |
Technavio's global whole exome sequencing market is segmented as below:
By Product
- Consumables
- Services
- Instruments
By Technology
- Sequencing by synthesis
- ION semiconductor sequencing
- Others
By Application
- Drug discovery and development
- Diagnostics
- Personalized medicine
- Prenatal and neonatal screening
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- The Netherlands
- Spain
- Russia
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the integration of artificial intelligence and machine learning for accelerated variant interpretation as one of the prime reasons driving the global whole exome sequencing market growth during the next few years. Also, proliferation of whole exome sequencing in population health initiatives and mainstream clinical practice and ascendancy of long read sequencing technologies for enhanced exome characterization will lead to sizable demand in the market.
The report on the global whole exome sequencing market covers the following areas:
- Global whole exome sequencing market sizing
- Global whole exome sequencing market forecast
- Global whole exome sequencing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global whole exome sequencing market vendors that include Agilent Technologies Inc., Ambry Genetics, Azenta US Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., CD Genomics, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., GeneDx LLC, Illumina Inc., Laboratory Corp., Macrogen Inc., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., PerkinElmer US LLC, ProPhase Labs, Inc., Psomagen Inc., QIAGEN N.V., Thermo Fisher Scientific Inc.. Also, the global whole exome sequencing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
5 Historic Market Size
- 5.1 Global Whole Exome Sequencing Market 2019 - 2023
- Historic Market Size - Data Table on Global Whole Exome Sequencing Market 2019 - 2023 ($ million)
- 5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
- 5.3 Technology segment analysis 2019 - 2023
- Historic Market Size - Technology Segment 2019 - 2023 ($ million)
- 5.4 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Five Forces Analysis
- 6.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 6.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 6.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 6.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 6.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 6.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 6.7 Market condition
7 Market Segmentation by Product
- 7.1 Market segments
- 7.2 Comparison by Product
- 7.3 Consumables - Market size and forecast 2024-2029
- 7.4 Services - Market size and forecast 2024-2029
- 7.5 Instruments - Market size and forecast 2024-2029
- 7.6 Market opportunity by Product
- Market opportunity by Product ($ million)
8 Market Segmentation by Technology
- 8.1 Market segments
- 8.2 Comparison by Technology
- 8.3 Sequencing by synthesis - Market size and forecast 2024-2029
- 8.4 ION semiconductor sequencing - Market size and forecast 2024-2029
- 8.5 Others - Market size and forecast 2024-2029
- 8.6 Market opportunity by Technology
- Market opportunity by Technology ($ million)
9 Market Segmentation by Application
- 9.1 Market segments
- 9.2 Comparison by Application
- 9.3 Drug discovery and development - Market size and forecast 2024-2029
- 9.4 Diagnostics - Market size and forecast 2024-2029
- 9.5 Personalized medicine - Market size and forecast 2024-2029
- 9.6 Prenatal and neonatal screening - Market size and forecast 2024-2029
- 9.7 Others - Market size and forecast 2024-2029
- 9.8 Market opportunity by Application
- Market opportunity by Application ($ million)
10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11.1 Geographic segmentation
- 11.2 Geographic comparison
- 11.3 North America - Market size and forecast 2024-2029
- 11.3.1 US - Market size and forecast 2024-2029
- 11.3.2 Canada - Market size and forecast 2024-2029
- 11.3.3 Mexico - Market size and forecast 2024-2029
- 11.4 Europe - Market size and forecast 2024-2029
- 11.4.1 Germany - Market size and forecast 2024-2029
- 11.4.2 UK - Market size and forecast 2024-2029
- 11.4.3 France - Market size and forecast 2024-2029
- 11.4.4 Italy - Market size and forecast 2024-2029
- 11.4.5 The Netherlands - Market size and forecast 2024-2029
- 11.4.6 Spain - Market size and forecast 2024-2029
- 11.4.7 Russia - Market size and forecast 2024-2029
- 11.5 Asia - Market size and forecast 2024-2029
- 11.5.1 China - Market size and forecast 2024-2029
- 11.5.2 Japan - Market size and forecast 2024-2029
- 11.5.3 India - Market size and forecast 2024-2029
- 11.5.4 South Korea - Market size and forecast 2024-2029
- 11.5.5 Indonesia - Market size and forecast 2024-2029
- 11.5.6 Thailand - Market size and forecast 2024-2029
- 11.5.7 Singapore - Market size and forecast 2024-2029
- 11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- 11.6.1 Australia - Market size and forecast 2024-2029
- 11.6.2 Brazil - Market size and forecast 2024-2029
- 11.6.3 UAE - Market size and forecast 2024-2029
- 11.6.4 South Africa - Market size and forecast 2024-2029
- 11.6.5 Saudi Arabia - Market size and forecast 2024-2029
- 11.6.6 Turkey - Market size and forecast 2024-2029
- 11.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
12 Drivers, Challenges, and Opportunity
- 12.1 Market drivers
- Technological advancements and precipitous decline in sequencing costs
- Expanding clinical utility and integration into standard diagnostic workflows
- Proliferation of large scale government and private precision medicine initiatives
- 12.2 Market challenges
- Bioinformatics bottleneck and complexity of data interpretation
- Inconsistent reimbursement policies and evolving regulatory landscapes
- Ethical, legal, and social implications (ELSI) surrounding data privacy and consent
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 12.4 Market opportunities
- Integration of artificial intelligence and machine learning for accelerated variant interpretation
- Proliferation of whole exome sequencing in population health initiatives and mainstream clinical practice
- Ascendancy of long read sequencing technologies for enhanced exome characterization
13 Competitive Landscape
- 13.1 Overview
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14.1 Companies profiled
- Companies covered
- 14.2 Company ranking index
- Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
- 14.5 Ambry Genetics
- Ambry Genetics - Overview
- Ambry Genetics - Product / Service
- Ambry Genetics - Key offerings
- SWOT
- 14.6 Azenta US Inc.
- Azenta US Inc. - Overview
- Azenta US Inc. - Business segments
- Azenta US Inc. - Key news
- Azenta US Inc. - Key offerings
- Azenta US Inc. - Segment focus
- SWOT
- 14.7 BGI Genomics Co. Ltd.
- BGI Genomics Co. Ltd. - Overview
- BGI Genomics Co. Ltd. - Product / Service
- BGI Genomics Co. Ltd. - Key offerings
- SWOT
- 14.8 CD Genomics
- CD Genomics - Overview
- CD Genomics - Product / Service
- CD Genomics - Key offerings
- SWOT
- 14.9 Eurofins Scientific SE
- Eurofins Scientific SE - Overview
- Eurofins Scientific SE - Business segments
- Eurofins Scientific SE - Key offerings
- Eurofins Scientific SE - Segment focus
- SWOT
- 14.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 14.11 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
- 14.12 Macrogen Inc.
- Macrogen Inc. - Overview
- Macrogen Inc. - Product / Service
- Macrogen Inc. - Key offerings
- SWOT
- 14.13 Novogene Co. Ltd.
- Novogene Co. Ltd. - Overview
- Novogene Co. Ltd. - Product / Service
- Novogene Co. Ltd. - Key offerings
- SWOT
- 14.14 Oxford Nanopore Technologies plc
- Oxford Nanopore Technologies plc - Overview
- Oxford Nanopore Technologies plc - Product / Service
- Oxford Nanopore Technologies plc - Key offerings
- SWOT
- 14.15 Pacific Biosciences of California Inc.
- Pacific Biosciences of California Inc. - Overview
- Pacific Biosciences of California Inc. - Product / Service
- Pacific Biosciences of California Inc. - Key news
- Pacific Biosciences of California Inc. - Key offerings
- SWOT
- 14.16 Psomagen Inc.
- Psomagen Inc. - Overview
- Psomagen Inc. - Product / Service
- Psomagen Inc. - Key offerings
- SWOT
- 14.17 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key news
- QIAGEN N.V. - Key offerings
- SWOT
- 14.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
15 Appendix
- 15.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- Research methodology
- 15.5 Data procurement
- Information sources
- 15.6 Data validation
- Data validation
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.8 Data synthesis
- Data synthesis
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations
- List of abbreviations
